LTBP3 and breast carcinoma: This signature included matrisome proteins that had previously been associated with breast cancer progression such as lysyl oxidase-like 2 (108) and angiopoietin-like 4 (109), and also identified known matrisome proteins that had never been associated with this disease before such as the latent TGFβ-binding protein 3 (LTBP3).